0000950170-24-000446.txt : 20240102 0000950170-24-000446.hdr.sgml : 20240102 20240102200015 ACCESSION NUMBER: 0000950170-24-000446 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240101 FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DICICCO WENDY F CENTRAL INDEX KEY: 0001225165 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36288 FILM NUMBER: 24504076 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akari Therapeutics Plc CENTRAL INDEX KEY: 0001541157 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 981034922 STATE OF INCORPORATION: X0 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF ROAD STREET 2: FL 7 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (646) 350-0702 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF ROAD STREET 2: FL 7 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Celsus Therapeutics Plc. DATE OF NAME CHANGE: 20130621 FORMER COMPANY: FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC DATE OF NAME CHANGE: 20120201 3 1 ownership.xml 3 X0206 3 2024-01-01 0 0001541157 Akari Therapeutics Plc AKTX 0001225165 DICICCO WENDY F C/O AKARI THERAPEUTICS, PLC 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 false true false false Interim CFO Stock Option (Right to Buy) 0.0017 2024-07-17 2033-07-17 Ordinary Shares, par value $0.0001 per share 5000000 D The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. One-hundered percent (100%) of the stock option vests and becomes exercisable on July 17, 2024 (first anniversary of the date of grant), subject to continued service with the Issuer. Notwithstanding the foregoing, should the Issuer terminate the Reporting Person for any reason other than for cause prior to the full vesting date, the stock option will continue to vest through the first anniversary of the date of grant or be accelerated, at the Issuer's option. /s/ Wendy DiCicco 2024-01-02